This event will bring together founders and partners as part of Glasgow’s growing SportsTech ecosystem.
SportsTech Evolution by SportsTech Scotland.

Get ready to dive into the exciting world of SportsTech right here in Scotland during Glasgow Tech Week.

Join Edge futures, MotionLabs, and SportsTech Scotland in person for an engaging afternoon exploring exciting the businesses that are leading the evolution of SportsTech right here on on our doorstep.

Shelley Breckenridge of Interface will be attending.

Scotland’s biggest sporting moment in more than a generation is here. As the country prepares to cheer on the national team at the World Cup — and Glasgow prepares to host the Commonwealth Games — a new wave of technologies is changing how we understand the human body. Not just for elite athletes, but for everyone. 

From wearable devices to AI-powered health tools, innovations once confined to specialist settings are now helping people monitor their health in real time, detect illnesses earlier, and gain deeper insights into their wellbeing. 

This Art of Possible session explores how Glasgow’s innovators are developing the next generation of health technologies — and how advances in sensing, diagnostics and data-driven insights are transforming the way we understand and manage human health.  This will be a valuable session for researchers, entrepreneurs, founders, clinicians, technology leaders, investors and anyone interested in the future of healthcare.

Transforming paediatric neurodiagnostics through AI‑enabled clinical data analysis to improve how childhood diseases are identified, diagnosed, and managed

Background

Seluna Ltd is a Scottish med‑tech startup whose work focuses on paediatric healthcare and transforming how childhood diseases are identified, diagnosed, and managed—starting with sleep‑disordered breathing. Through a collaboration with the University of Glasgow supported by Interface and an Innovation Voucher, Seluna has taken a major step toward enabling accurate diagnosis of childhood obstructive sleep disordered breathing through AI‑driven analysis of wearable and hospital device data.

Childhood sleep‑disordered breathing, particularly obstructive sleep apnoea, is a common yet under‑diagnosed condition with significant short‑ and long‑term health consequences. Seluna Ltd was established to address this unmet clinical need by combining advanced software, data science, and machine‑learning expertise with clinically grounded innovation.

The Challenge

Approximately 4% of children are affected by obstructive sleep apnoea, yet an estimated 80% remain undiagnosed. Current diagnostic pathways rely on hospital‑based overnight sleep studies that are slow, expensive, labour‑intensive, and dependent on scarce specialist staff. These constraints place significant pressure on NHS services and mean many children never receive a sleep study or appropriate treatment.

Seluna had already developed machine‑learning software capable of automating sleep‑study analysis, tackling a major bottleneck in the diagnostic process. However, the challenge remains that an accurate diagnosis still requires an in-hospital study.

The Solution

Through an Interface‑funded Innovation Voucher project running from November 2024 to February 2025, Seluna partnered with the University of Glasgow to develop a novel AI algorithm pipeline, capable of identifying sleep apnoea from wearable cardiorespiratory signals. This was a feasibility study to show that Seluna’s custom AI data analytics, paired with existing wearable technology, may allow for accurate, home-based testing in children.

Interface played a critical role by initiating and funding the collaboration, enabling Seluna to access world‑leading expertise and facilities that were not available in‑house or commercially. The academic team – led by Dr Jack Radford and Professor Daniele Faccio’s Extreme Light Group—provided specialist knowledge in biophotonics, signal processing, machine learning, light–tissue interaction, optical signal acquisition, and experimental design. Their laboratory infrastructure and academic expertise enabled rapid feasibility testing and optimisation.

The collaboration was highly synergistic, combining Seluna’s strengths in AI, signal processing, and clinical data analysis with the University’s deep expertise in biosensors. The project was further supported by clinicians from NHS Greater Glasgow & Clyde, Royal Hospital for Children, Sleep & Respiratory Medicine, ENT, and Clinical Physics, exemplifying a strong industry–academia–healthcare partnership.

Company Benefits

• The proof of concept generated through the Interface‑supported project directly contributed to Seluna securing £580,000 in private investment in June 2025, enabling the creation of two new full‑time roles and safeguarding four existing positions.
• The collaboration strengthened Seluna’s credibility in deep‑tech medical innovation and supported the award of £267k in additional public funding, including the Innovate UK Women in Innovation Award (£70,000, December 2024) and a Scottish Enterprise implementation grant (£48,000, July 2025).
• Clinically, the work enabled Seluna to launch a 500‑patient Phase 1 clinical validation study with NHS Greater Glasgow & Clyde and to establish new collaborations with NHS Sheffield, NHS Southampton, and leading paediatric hospitals in the United States.
• Also it allowed Seluna to establish a long-lasting collaboration with the University of Glasgow, which continues to drive and accelerate R&D activities today.

Academic Benefits

• The project delivered significant academic impact, particularly for Dr Radford, for whom it represented the first opportunity to secure and lead an independent grant – an important milestone toward academic independence. It provided clear evidence of translational research, demonstrating how biophotonics expertise can address actual clinical and industrial challenges.
• The collaboration expanded the research group’s engagement with industry‑partnered funding and international networks. Follow‑on funding supported research visits to Boston in March 2025, strengthening links with MIT, Harvard University, and major US paediatric hospitals.
• The Interface project led directly to an extended consultancy agreement with Seluna, the award of an SFC QuantumARC grant, and the University of Glasgow’s involvement in a wider Innovate UK programme with Seluna, reinforcing long‑term strategic collaboration.

Next Steps

• Seluna and the University of Glasgow will continue working through an ongoing consultancy to deliver a research prototype device in 2026, supporting further investment and clinical validation.
• Seluna is planning a UK‑wide multicentre Phase 2 clinical study beginning in February 2026, alongside parallel preparations for US‑based studies.
• From an academic perspective, the results of the Interface project are supporting fellowship applications and a proposed co‑funded PhD studentship aimed at translating biophotonics research into commercial IP and product development. These next steps ensure sustained impact for both Seluna and the academic partners.

SGSSS Collaboration and Impact Showcase 2026 at The Royal Society of Edinburgh is a day celebrating the research, exciting collaborations, and impactful projects of SGSSS PhD students.

The SGSSS annual Collaboration and Impact Showcase brings together University and external partners from across the network who support the work of the Scottish Graduate School and SGSSS students.

This year, keynote speaker Dr Fran Darlington-Pollok will share insights into ‘Making a difference with Social Science‘, exploring how social science research can inform interventions that address inequalities across sectors. Fran is the Executive Chief Adviser to the Vice Chancellor at the University of Salford, and has experience across academic and third-sector roles, including as CEO of the Greater Manchester Mayor’s Charity.

The event will also include a poster session showcasing SGSSS students’ impact work, a panel discussion with students and collaborative partners and the presentation of the annual Impact Award to students who, through their research impact, have made a demonstrable contribution to society and the economy. There will also be a chance to meet informally with other SGSSS partners, students, and the SGSSS directorate.

The afternoon will finish with the presentation of our Impact Competition Winners and closing remarks from Prof Sarah Skerrett, RSE Chief Executive.

Glasgow has a long history of innovation, and today that same spirit is pushing the boundaries of how we design and interact with technology. This GCoSI Deep Dive explores a different perspective: what happens when we create technology not just for humans, but for animals too? 

Focusing on the field of animal–computer interaction, this session explores how animals engage with technology — from building the “dog internet” to parrots video-calling each other and interactive environments for zoo animals. What does this reveal about intelligence, behaviour and how we design?

Join Dr Ilyena Hirskyj-Douglas, an Animal-Computer Interaction researcher at the University of Glasgow and Director of the Animal-Computer Interaction Lab for an open, story-led conversation exploring how animals interact with technology — and what it means to design for users beyond humans.

The Industrial Biotechnology Innovation Centre (IBioIC) in partnership with the BioBased and Biodegradable Industries Association (BBIA), holds its 12th Annual Conference in Glasgow on 10 and 11 March 2026.

The conference will bring together over 400 biobased industry professionals, researchers, policymakers, and supporting organisations to hear talks, case studies, and panel sessions and to take part in networking activities and workshops.

Visit the exhibition, innovation zone, and posters zone, take part in extensive informal networking opportunities and 1-1 partnering, and join an all-welcome civic reception at Glasgow City Chambers.

Conference attendees are made up of predominantly C-suite or senior level industry representatives from both large, established companies and emerging and start-up enterprises, as well as senior academics, researchers in industry or academia, students and recent graduates, investors, and policy makers. The conference focuses on delivering tangible benefits for attendees, including cultivating strategic partnerships, facilitating new connections and collaborations, providing examples of best practice, understanding, and feeding back on, regulations, and supporting effective communication.

The theme of this year’s conference is BioSolutions for Tomorrow’s World. Fast paced sessions will explore topics ranging from bio-similars in manufacturing to food innovation and the role of biotechnology in restoring natural environments. We’ll look into key issues such as the extent to which bio-based products can replace fossil, and factors influencing the adoption of alternative proteins, while fireside chats and panel sessions will delve into issues in depth. Sponsored workshops on Day 2 will give hosts and delegates an opportunity to discuss issues in-depth in an interactive and outcome-driven setting, and informal networking and 1-1 partnering throughout will give delegates opportunities to meet key contacts and build new connections.

The Scottish Universities Life Sciences Alliance (SULSA) IndAc25 Conference is a dynamic two-day conference and careers fair bringing together life sciences industry and academia to explore the latest in industry-academia collaboration, commercialisation, and career development.

Day one focuses on industry-academia collaboration and commercialisation with ample opportunities to network with commercially minded academics, industry open to collaboration and organisations that can support.

Day two focuses on employability and skills development and run similar to a recruitment fair providing the chance for talented and proactive undergraduate and postgraduate students and staff to network with life sciences employers.

Interface are taking part in a panel session and have an exhibition stand, so drop by and meet Shelley Breckenridge, Jackie Sanderson and Gillian Hambley.

Aligning Research with Real-World Impact

Life Sciences Partnerships Day on Wednesday 1st October 2025 will be a day of connection, collaboration and innovation bringing together academic researchers, funders, industry and other external organisations to explore how the University of Glasgow’s life sciences expertise can help tackle real-world challenges.

This event is designed to create space for meaningful engagement between Medical, Veterinary & Life Sciences (MVLS) researchers and external organisations. Through a combination of keynote talks, industry-led pitches, collaborative workshops, and networking opportunities, the day aims to:

• Showcase MVLS research strengths and ambitions
• Identify opportunities for collaborative problem-solving
• Facilitate conversations around funding, skills development, and translational impact
• Build lasting partnerships to address key societal challenges with a focus on human and animal health, life sciences, and the environment
  

Meet Interface’s Gillian Hambley and Jackie Sanderson at this event.

Accelerate your HealthTech solution with University of Glasgow’s Evidence Generation Bootcamp!

Building on the success of the inaugural bootcamp last year, the Digital Health Validation Lab is hosting its second edition on Wednesday 1st and Thursday 2nd of October. This two-day, hands-on event is designed for HealthTech innovators who are ready to accelerate their solutions and drive real-world impact.

In today’s fast-moving and competitive HealthTech landscape, robust evidence is critical to achieving regulatory approval, adoption, scale, and long-term success. This bootcamp provides a practical framework to help you confidently navigate the complexities of evidence generation and build a clear, actionable strategy aligned with your innovation and route to market.

Through expert-led sessions, you’ll gain:

• Clarity on your evidence requirements and how to address them effectively
• Confidence to engage key stakeholders with timely, relevant evidence and navigate complex evidence demands
• A personalised roadmap for evidence generation, tailored to your solution and market strategy
• Improved understanding of approaches to: Patient and Public Involvement (PPI); concept validation; health economic modelling; simulation; technical feasibility and AI performance testing; clinical investigations for regulatory approval; and clinical and cost-effectiveness studies to support adoption.

Who should attend?

HealthTech startups, SMEs, innovation leads, and academic researchers ready to turn a great solution into an evidence-backed, scalable success.

Headline speakers include:

Professor Olivia Wu is a globally recognised authority in Health Technology Assessment (HTA). She holds the prestigious William R Lindsay Chair of Health Economics at the University of Glasgow’s HEHTA and serves as Adjunct Professor at the Faculty of Pharmacy at Mahidol University in Thailand.

Professor Neil Hawkins is a Professor of Health Technology Assessment (HTA) at the University of Glasgow, where he brings decades of cross-sector experience to advancing evidence-based healthcare decision-making. His career spans academia, industry, and consultancy, with contributions across pharmacology, clinical development, epidemiology, and HTA.

Professor David Lowe is an Emergency Consultant at Queen Elizabeth University Hospital (QEUH), Clinical Director of Innovation at the University of Glasgow, and Clinical Director for Health Innovation for the Scottish Government.

Ticket Price

£295.00 – Early Bird Rate (until 15 August 2025)

£350.00 – Standard Rate (from 16 August 2025)

Please note that registration will close on Friday 19 September.